(Q48431363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

V T Ramaekers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

B Thöny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J M Sequeira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M Ansseau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

P Philippe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

V Bours

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

E V Quadros

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

12 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

307-314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25456743%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

The molecular genetics of schizophrenia: new findings promise new insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

NMDA receptor and schizophrenia: a brief history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Psychedelics and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Disease-relevant autoantibodies in first episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Folate and cobalamin in psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Schizophrenia and single-carbon metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Enhancement of recovery from psychiatric illness by methylfolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

S-Adenosylmethionine and methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Carrier-mediated membrane transport of folates in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Cerebral folate deficiency presenting as adolescent catatonic schizophrenia: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Autoantibodies to folate receptors in the cerebral folate deficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

The diagnostic utility of folate receptor autoantibodies in blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Phenotypic manifestations of copy number variation in chromosome 16p13.11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Antibodies to folate receptors impair embryogenesis and fetal development in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Cerebral folate receptor autoantibodies in autism spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002

Folate deficiency in rat pups during weaning causes learning and memory deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.10.002